October 20, 2022 The National Cancer Institute has awarded UNC researchers $10.9 million in funding to further enhance treatment solutions for pancreatic cancer by focusing on key challenges to identifying, producing and directing new therapies.
October 19, 2022 The National Cancer Institute awarded $9.3 million in support of two five-year research projects led by researchers at UNC.
September 27, 2022 A new JAMA study of more than 10 million North Carolinians highlights just how effective COVID-19 vaccines, boosters and prior infection can be, both in reducing the risk of future infection and in preventing hospitalization and death.
September 15, 2022 Dr. Danyu Lin led research recently published in the New England Journal of Medicine that assesses the level of immunity conferred by COVID-19 vaccination or previous SARS-CoV-2 infection among children. The findings provide crucial information for making decisions about vaccine boosters for children.
September 15, 2022 During the Fall 2020 semester, UNC explored hybrid options to minimize COVID-19 transmission while still offering an on-campus experience for students. New research from the Gillings School sheds light on how this experience impacted COVID-19 cases among undergraduates.
August 30, 2022 Dr. Michael R. Kosorok has been named president-elect of the Institute of Mathematical Statistics, a nonprofit organization that fosters the development and dissemination of theory and applications of statistics and probability.
August 29, 2022 Dr. Jane Monaco will serve as the Gillings School's assistant dean of undergraduate degree programs beginning Sept. 1.
August 18, 2022 "Our message is that people should take as many steps as possible throughout the day at any walk pace, trying to work in a brisk walk for part of the day to gain the greatest benefit in lowering their risk of diabetes."
August 12, 2022 Gillings faculty have recently completed four GILs, including two from Round 6 of GIL funding and two from the special COVID-19 round of funding. The results of their work have furthered our understanding of energy storage, brain health, environmental exposures, viral transmission, pandemic response and more.
July 15, 2022 A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.
